BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2070084)

  • 21. Immunobiologic differences between normal and leukemic human B-cell precursors.
    Uckun FM; Ledbetter JA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of 5'nucleotidase in acute lymphoblastic leukemia with the common-ALL phenotype.
    Veerman AJ; Hogeman PH; van Zantwijk CH; Bezemer PD
    Leuk Res; 1985; 9(10):1227-9. PubMed ID: 2999518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased 5' nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with the acquired immune deficiency syndrome.
    Murray JL; Reuben JM; Munn CG; Mansell PW; Newell GR; Hersh EM
    Blood; 1984 Nov; 64(5):1016-21. PubMed ID: 6091811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytic ecto 5'-nucleotidase (ecto-5'NT) levels in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Singh Ghalaut V; Dahiya K; Ghalaut PS; Batra S; Dhankhar R
    Clin Chim Acta; 2006 Feb; 364(1-2):359-60. PubMed ID: 16176810
    [No Abstract]   [Full Text] [Related]  

  • 25. Redistribution of ecto-5'-nucleotidase during phagocytosis by guinea pig polymorphonuclear leukocytes.
    Cramer E; Werb Z; Bainton DF
    J Leukoc Biol; 1984 Oct; 36(4):463-75. PubMed ID: 6090556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic and virologic findings in hemophiliacs do not correlate with ecto-5'nucleotidase activity of peripheral blood lymphocytes. A difference with homosexual men.
    Massaia M; Pioppo P; Dianzani U; Guerra MG; Peyretti F; Pileri A; Tamponi G
    Eur J Haematol; 1987 Apr; 38(4):310-4. PubMed ID: 3038600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
    Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
    Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple myeloma: ecto-5' nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells.
    Massaia M; Dianzani U; Pioppo P; Sibilla E; Boccadoro M; Pileri A
    Clin Exp Immunol; 1987 Aug; 69(2):426-32. PubMed ID: 2820641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte 5'-nucleotidase activities in normal dogs and in dogs with malignant lymphoma.
    Sarmiento UM; Valli VE
    Vet Immunol Immunopathol; 1986 Dec; 13(4):281-8. PubMed ID: 3029941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
    Smith RG; Kitchens RL
    Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3).
    Ho AD; Ma DD; Price G; Hoffbrand AV
    Leuk Res; 1983; 7(6):779-86. PubMed ID: 6319830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexpression of cell-surface immunoglobulin (sIg), terminal deoxynucleotidyl transferase (TdT) and recombination activating gene 1 (RAG-1): two cases and derived cell lines.
    Nakamura F; Tatsumi E; Tani K; Kumagai S; Kosaka Y; Sano K; Nakamura H; Nesumi N; Abe T; Koiwai O
    Leukemia; 1996 Jul; 10(7):1159-63. PubMed ID: 8683996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
    Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells.
    Ma DD; Massaia M; Sylwestrowicz TA; Price G; Hoffbrand AV
    Br J Haematol; 1983 Jul; 54(3):451-7. PubMed ID: 6305393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Fukunaga Y; Evans SS; Yamamoto M; Ueda Y; Tamura K; Takakuwa T; Gebhard D; Allopenna J; Demaria S; Clarkson B
    Blood; 1989 Nov; 74(7):2486-92. PubMed ID: 2553165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monastrol-derived compound, LaSOM 63, inhibits ecto-5'nucleotidase/CD73 activity and induces apoptotic cell death of glioma cell lines.
    Figueiró F; Mendes FB; Corbelini PF; Janarelli F; Jandrey EH; Russowsky D; Eifler-Lima VL; Battastini AM
    Anticancer Res; 2014 Apr; 34(4):1837-42. PubMed ID: 24692717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.